Avopef
NDC 83831-144, etoposide, injection, from AVYXA Pharma, LLC.
- Product NDC
- 83831-144
- Status
- Listed
- Labeler
- AVYXA Pharma, LLC
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA220200
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83831-144 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ETOPOSIDE100 mg/5mL
Pharmacologic classes
Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83831-144-05 | 83831014405 | 1 VIAL in 1 CARTON (83831-144-05) / 5 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/acc1e443-ef7b-486f-a638-710a20e81059Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=83831-144
Use it
Look up 83831-144 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83831-144 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83831-144. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.